Lutronic® Announces FDA Clearance of AccuSculpt™, the first and only 1444 nm wavelength device for laser-assisted lipolysis
Lutronic, Inc., a leading developer of high quality, affordable medical and aesthetic laser systems recently announced it received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the new AccuSculpt™ Laser Lipolysis System.
The most powerful tool in Laser Assisted Lipolysis (LAL), AccuSculpt™ is indicated for Laser Assisted Lipolysis. The AccuSculpt™ is further indicated for the surgical incision, excision, vaporization, ablation, and coagulation of soft tissue. All soft tissue is included, such as skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage, meniscus, mucous membrane, lymph vessels and nodes, organs and glands.
“With the FDA clearance of the AccuSculpt™ system and its revolutionary 1444 nm wavelength, we are poised to capitalize on the continued growth of Laser Assisted Lipolysis and body contouring,” noted Jhungwon Hwang, Ph.D, Senior Director of Regulatory Affairs. “This new advancement supports an intrinsic tradition of innovation at Lutronic. Our expansion into body contouring, one of the fastest growing segments in aesthetic medicine, reflects our welldefined ability to respond to the needs of the global aesthetic market.”
AccuSculpt™ from Lutronic is the first and only Pulsed Nd:YAG Laser to deliver the revolutionary 1444 nm wavelength for the most accurate, precise, controlled, minimally-invasive deep tissue heating currently available. To meet consumer demand for less invasive body shaping procedures and ease concerns about cost and recovery time, the AccuSculpt™ system was designed to safely and efficiently emulsify fat, improve physical contouring and the appearance of skin laxity, as well as reduce bruising and other side effects commonly associated with liposuction and other LAL treatments. Patients experience virtually little to no downtime following treatment.
“Because the AccuSculpt is more accurate, fat is removed only from fatty compartments without hurting other important structures like nerves and vessels,” said Daniel Man, M.D., a boardcertified plastic surgeon in private practice in Boca Raton, Florida. “It significantly reduces post-operative discomfort or pain. Recovery is shorter as patients often return to work and other activities in a few days.”
Lutronic is a leading developer and manufacturer of medical laser systems for dermatological and aesthetic surgery applications. The Company’s advanced technologies include the eCO2 fractional laser, the Spectra family of products and the unparalleled MOSAIC fractional system. With distribution in over 41 countries and more than a decade of award-winning advances in research and development, Lutronic is committed to delivering innovative, highly effective and versatile laser solutions at exceptional value. Dedicated customer care and clinician support worldwide are a primary focus at Lutronic. To learn more about the company’s portfolio of laser systems, please visit www.lutronic.com.